Up and down the ladder: The latest comings and goings

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. Please note that our regular feature — in which we spotlight someone — will return next week.

McKesson hired Michele Lau as executive vice president and chief legal officer;

BioMarin Pharmaceuticals says chief executive officer Jean-Jacques Bienaimé is retiring on Dec. 1;

Get unlimited access to award-winning journalism and exclusive events.

Study: 97% of Patients Are Confident AI Will Elevate Patient Care

What You Should Know: – A new study by Upvio, a leading digital care platform, titled “State of AI and Technology Adoption in Healthcare,” provides

September 20, 2024

Soft drinks worsen menstrual pain, study shows

Soft drink intake is linked to a higher likelihood and severity of primary dysmenorrhea in Chinese women, especially in rural areas, while moderate coffee consumption

September 16, 2024

Tirzepatide Shortage Resolved; Compounder Sues FDA; Menopause Mistaken as Dementia

All doses of the diabetes and weight management injectable tirzepatide (Mounjaro, Zepbound) were taken off the FDA’s shortage list. (Reuters) This prompted a compounding group

October 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.